Validation of a Cost-Effective RP-HPLC Method for Quantitative Investigation of Daclatasvir Dihydrochloride in Pharmaceutical Formulations

Validation of a Cost-Effective RP-HPLC Method for Quantitative Investigation of Daclatasvir Dihydrochloride in Pharmaceutical Formulations

A well-known direct-acting antiviral (DAA) drug called daclatasvir may be used to treat chronic hepatitis C virus (HCV) infection. Herein, we reported a selective, precise, and a cost-effective analytical method for the measurement of an active pharmaceutical ingredient (API) of daclatasvir dihydroc...

Full description

Bibliographic Details
Main Authors: Sadaf Sarfraz, Muhammad Saeed, Mohsin Javed, Nadia Hussain, Shahid Iqbal, Shahid Amin, Ali Bahadur, Ahmed Hussain Jawhari, Randa A. Althobiti, Eman Alzahrani, Abd-ElAziem Farouk, Samar O. Aljazzar, Eslam B. Elkaeed
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2023/4908091

Internet

http://dx.doi.org/10.1155/2023/4908091

Similar Items